✦ LIBER ✦

216 POSTER A phase I dose-escalation study of the safety, pharmacokinetics and pharmacodynamics of XL765, a novel inhibitor of PI3K and mTOR, administered orally to patients with solid tumors

✍ Scribed by B. Markman; P.M. LoRusso; A. Patnaik; E. Heath; A.D. Laird; B. van Leeuwen; K.P. Papadopoulos; J. Baselga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

218 POSTER A phase I dose-escalation stu

✍ E. Calvo; G. Edelman; J. Baselga; E. Kwak; C. Scheffold; L. Nguyen; G.I. Shapiro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

97 POSTER A phase I dose-escalation stud

✍ K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

405 POSTER A phase I dose-escalation stu

✍ R. Kurzrock; L. Camacho; D. Hong; C. Ng; L. Janisch; M.J. Ratain; R. Salgia 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Phase I safety, pharmacokinetic, and pha

✍ Markman, B.; Tabernero, J.; Krop, I.; Shapiro, G. I.; Siu, L.; Chen, L. C.; Mita 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 362 KB

397 POSTER A phase I dose escalation and

✍ R.A. Fleming; K.D. Holen; T.L. Cyr; B.M. Johnson; J.L.S. Gauvin; J.J. Lager; B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB